REGISTERED
on 01 Mar 2022
Last Applicant/ Owned by
Level 3,
AU
Serial Number
79280774 filed on 09th Jan 2020
Registration Number
6655611 registered on 01st Mar 2022
Correspondent Address
Elizabeth M. O'Donoghue
Filing Basis
No Filing Basis
Disclaimer
NO DATA
ZELIRA
Preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cogniti Read More
Classification Information
Class [005]
Pharmaceutical Products
Preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder; none of the foregoing being preparations to treat deficiencies of Alpha-One proteinase inhibitors; none of the goods being for the treatment and detection of cervical cancer and related infections
Class [042]
Computer & Software Services & Scientific Services
Conducting clinical trials for others; research relating to science; provision of pharmaceutical research services; project management and planning of clinical trials, namely, consulting services for others in the field of design, planning, and implementation project management of clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; scientific research relating to medicinal use of cannabis; scientific research and development of medicinal cannabis products; medical research; scientific research for medical purposes; scientific research; none of the foregoing in relation to the treatment of deficiencies of Alpha-One proteinase inhibitors; none of the services being for the treatment and detection of cervical cancer and related infections
Mark Details
Serial Number
No 79280774
Mark Type
No Service Mark
Attorney Docket Number
No 191146-5003
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Jun 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 01st Mar 2022 | REGISTERED-PRINCIPAL REGISTER |
| 02th Feb 2022 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| 19th Dec 2021 | NOTIFICATION PROCESSED BY IB |
| 14th Dec 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 14th Dec 2021 | PUBLISHED FOR OPPOSITION |
| 24th Nov 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 24th Nov 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 24th Nov 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 21st Nov 2021 | LIMITATION OF GOODS RECEIVED FROM IB |